These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22512247)

  • 1. Glioblastoma--a moving target.
    Westermark B
    Ups J Med Sci; 2012 May; 117(2):251-6. PubMed ID: 22512247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent perspectives of molecular aberrations in pediatric high-grade glioma.
    Li Z; Sun Q; Shi Y
    Minerva Pediatr; 2020 Apr; 72(2):116-122. PubMed ID: 28643992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.
    Venkatesan S; Lamfers ML; Dirven CM; Leenstra S
    CNS Oncol; 2016; 5(2):77-90. PubMed ID: 26986934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.
    Chow LM; Endersby R; Zhu X; Rankin S; Qu C; Zhang J; Broniscer A; Ellison DW; Baker SJ
    Cancer Cell; 2011 Mar; 19(3):305-16. PubMed ID: 21397855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.
    Firat E; Niedermann G
    Oncotarget; 2016 Aug; 7(34):54883-54896. PubMed ID: 27448972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology of glioblastoma.
    Aguda BD
    Curr Drug Discov Technol; 2013 Jun; 10(2):125-38. PubMed ID: 23237675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells.
    Cong ZX; Wang HD; Wang JW; Zhou Y; Pan H; Zhang DD; Zhu L
    Oncol Rep; 2013 Aug; 30(2):715-22. PubMed ID: 23708697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
    Tuncel G; Kalkan R
    Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of Wilson's disease and glioblastoma multiforme--is it a chance association?
    Sinha S; Prashanth LK; Mahadevan A; Satish S; Ravishankar S; Arunodaya GR; Taly AB; Shankar SK
    Clin Neuropathol; 2004; 23(5):241-4. PubMed ID: 15581028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
    Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
    Knobbe CB; Reifenberger G
    Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma.
    Kim B; Myung JK; Seo JH; Park CK; Paek SH; Kim DG; Jung HW; Park SH
    J Neurol Sci; 2010 Jul; 294(1-2):112-8. PubMed ID: 20441994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status.
    Kinashi Y; Ikawa T; Takahashi S
    Appl Radiat Isot; 2020 Sep; 163():109204. PubMed ID: 32561044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kinase signaling in glioblastoma.
    Lino MM; Merlo A
    J Neurooncol; 2011 Jul; 103(3):417-27. PubMed ID: 21063898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes and PI3K bind CD95 to signal invasion of glioblastoma.
    Kleber S; Sancho-Martinez I; Wiestler B; Beisel A; Gieffers C; Hill O; Thiemann M; Mueller W; Sykora J; Kuhn A; Schreglmann N; Letellier E; Zuliani C; Klussmann S; Teodorczyk M; Gröne HJ; Ganten TM; Sültmann H; Tüttenberg J; von Deimling A; Regnier-Vigouroux A; Herold-Mende C; Martin-Villalba A
    Cancer Cell; 2008 Mar; 13(3):235-48. PubMed ID: 18328427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the p53 and pRB pathways in human astrocytoma.
    Rutka JT; Akiyama Y; Lee SP; Ivanchuk S; Tsugu A; Hamel PA
    Brain Tumor Pathol; 2000; 17(2):65-70. PubMed ID: 11210173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.
    Koul D; Fu J; Shen R; LaFortune TA; Wang S; Tiao N; Kim YW; Liu JL; Ramnarian D; Yuan Y; Garcia-Echevrria C; Maira SM; Yung WK
    Clin Cancer Res; 2012 Jan; 18(1):184-95. PubMed ID: 22065080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.